
2022年
new order | old order


RevolKa has been selected as a member of the Google for Startups Cloud Program.

RevolKa has been selected as a member of the Google for Startups Cloud Program.

Presenting at Antibody Engineering & Therapeutics

Presenting at Antibody Engineering & Therapeutics

New Tokyo lab has been opened.

Our advertisement feature was published in the online version of Nature

Our advertisement feature was published in the online version of Nature

An interview with our CEO Kataoka was published in the LINK-J

Started a joint research collaboration with Tokyo Medical and Dental University
LATEST ARTICLE
ARCHIVE
- 2023/11 (1)
- 2023/10 (2)
- 2023/09 (2)
- 2023/08 (2)
- 2023/06 (3)
- 2023/05 (1)
- 2023/04 (3)
- 2023/02 (6)
- 2023/01 (2)
- 2022/12 (1)
- 2022/11 (5)
- 2022/10 (5)
CATEGORY
View allTAG